Balci O and Gulkilik G |
Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction. |
2018 |
Clin Exp Optom |
pmid:28677153
|
Afghani T et al. |
Preventing Long-Term Ocular Complications of Trachoma With Topical Azithromycin: A 3-Year Follow-up Study. |
2017 Jan-Feb |
Asia Pac J Ophthalmol (Phila) |
pmid:28161923
|
González-Beiras C et al. |
Single-Dose Azithromycin for the Treatment of Haemophilus ducreyi Skin Ulcers in Papua New Guinea. |
2017 |
Clin. Infect. Dis. |
pmid:29020192
|
Kirk SK et al. |
Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. |
2017 |
J. Vet. Intern. Med. |
pmid:28625019
|
Vajpayee S et al. |
Scrub typhus causing neonatal hepatitis with acute liver failure-A case series. |
2017 |
Indian J Gastroenterol |
pmid:28612320
|
Koeva M et al. |
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923873
|
Liu D et al. |
Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2. |
2017 |
PLoS ONE |
pmid:28976984
|
Kibuule D et al. |
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications. |
2017 |
Int. J. Clin. Pract. |
pmid:28090718
|
Pokharel S et al. |
Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. |
2017 |
Trials |
pmid:28969659
|
Brown JD et al. |
Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961759
|
Jacobsson S et al. |
Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28893785
|
Idkaidek N et al. |
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System. |
2017 |
Drugs R D |
pmid:28074334
|
Gomes C et al. |
Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin. |
2017 |
Crit. Rev. Microbiol. |
pmid:27786586
|
Kwakye-Maclean C et al. |
A Single Dose Oral Azithromycin versus Intramuscular Benzathine Penicillin for the Treatment of Yaws-A Randomized Non Inferiority Trial in Ghana. |
2017 |
PLoS Negl Trop Dis |
pmid:28072863
|
Fu L et al. |
Toxicity of 13 different antibiotics towards freshwater green algae Pseudokirchneriella subcapitata and their modes of action. |
2017 |
Chemosphere |
pmid:27783962
|
Xiao Z et al. |
Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on Mycoplasma pneumoniae pneumonia. |
2017 |
J Nat Med |
pmid:28664473
|
Atkinson CT et al. |
Expression of acquired macrolide resistance genes in Haemophilus influenzae. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961896
|
Lendermon EA et al. |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation. |
2017 |
Respir. Res. |
pmid:28659178
|
Zhang C et al. |
Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China. |
2017 |
Microb. Drug Resist. |
pmid:27841958
|
Segal LN et al. |
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. |
2017 |
Thorax |
pmid:27486204
|